Modulation of the antioxidant enzyme paraoxonase-1 for protection against cardiovascular diseases

被引：1
|
作者：
Dornas, Waleska [1 ]
Silva, Maisa [2 ]
机构：
[1] Univ Fed Minas Gerais, Sch Med, Course Super Technol Radiol, Belo Horizonte, MG, Brazil
[2] Univ Fed Juiz De Fora, Dept Basic Life Sci, Governador Valadares, MG, Brazil
来源：
NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES | 2024年 / 34卷 / 12期
关键词：
Paraoxonase; 1; Inflammation; Antioxidant response; Lipoperoxidation; HDL; Atherosclerosis; HIGH-DENSITY-LIPOPROTEIN; HIGH-FAT DIET; INCREASES SERUM PARAOXONASE; POMEGRANATE JUICE CONSUMPTION; CHOLESTEROL EFFLUX CAPACITY; C-REACTIVE PROTEIN; OXIDATIVE STRESS; GENE-EXPRESSION; PON1; GENE; LIPID-PEROXIDATION;
D O I：
10.1016/j.numecd.2024.04.005
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Aim: The enzyme paraoxonase 1 (PON1) bound to high-density lipoprotein has received special attention for its protective role against stress-mediated damage and use as a potential regulatory target in atherosclerosis and related vascular diseases. Data synthesis: We present an overview of the literature on PON1 activity and mRNA levels by investigating its modulation for clinical translations. Specifically, the expression of PON1 and its regulated activity can be modified in different ways with natural substances, drugs, and lifestyle factors thar affect the development of atherosclerosis. Conclusions: The endothelial contribution of PON1 to overcome differences considering an individual's disease development risk is supported by polymorphism interaction data and the susceptibility to modify PON1 responses in chronic events composed by biological and environmental factors. (c) 2024 The Italian Diabetes Society, the Italian Society for the Study of Atherosclerosis, the Italian Society of Human Nutrition and the Department of Clinical Medicine and Surgery, Federico II University. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码：2611 / 2622
页数：12
相关论文
共 50 条
  • [21] Inhibition Effects of Oncological Drugs for Treatment of Cancer, on Paraoxonase-1 Enzyme (PON1) Activity and Cardiovascular Toxicity
    Soeyuet, Hakan
    INTERNATIONAL JOURNAL OF PHARMACOLOGY, 2023, 19 (01) : 13 - 13
  • [22] Monitoring of the lactonase activity of paraoxonase-1 enzyme in HIV-1-infection
    Dias, Clara
    Marinho, Aline
    Morello, Judit
    Almeida, Gabriela
    Caixas, Umbelina
    Soto, Karina
    Monteiro, Emilia
    Pereira, Sofia A.
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2014, 17 : 125 - 125
  • [23] Distribution of paraoxonase-1 gene polymorphisms and enzyme activity in a Peruvian population
    Catano, Hector C.
    Cueva, Jayme L.
    Cardenas, Anthony M.
    Izaguirre, VIctor
    Zavaleta, Amparo I.
    Carranza, Elizabeth
    Hernandez, Antonio F.
    ENVIRONMENTAL AND MOLECULAR MUTAGENESIS, 2006, 47 (09) : 699 - 706
  • [24] Serum paraoxonase-1 gene polymorphism and enzyme activity in patients with urolithiasis
    Atar, Arda
    Gedikbasi, Asuman
    Sonmezay, Erkan
    Kiraz, Zeynep Kusku
    Abbasoglu, Semra
    Tasci, Ali Ihsan
    Tugcu, Volkan
    RENAL FAILURE, 2016, 38 (03) : 378 - 382
  • [25] Total antioxidant and total oxidant states, and serum paraoxonase-1 in neonatal sepsis
    Annagur, Ali
    Ors, Rahmi
    Altunhan, Huseyin
    Kurban, Sevil
    Ertugrul, Sabahattin
    Konak, Murat
    Uygun, Saime Sunduz
    Pekcan, Sevgi
    Erbay, Ekrem
    Mehmetoglu, Idris
    PEDIATRICS INTERNATIONAL, 2015, 57 (04) : 608 - 613
  • [26] Paraoxonase-1 Enzyme Activity Assay for Clinical Samples: Validation and Correlation Studies
    Garelnabi, Mahdi
    Younis, Abdelmoneim
    MEDICAL SCIENCE MONITOR, 2015, 21 : 902 - 908
  • [27] Abnormal paraoxonase-1 (PON1) enzyme activity in idiopathic inflammatory myopathies
    Bae, Sangmee Sharon
    Shahbazian, Ani
    Wang, Jennifer
    Golub, Ilana
    Oganesian, Buzand
    Dowd, Tyler
    Vayngortin, Beata
    Wang, Ryan
    Elashoff, David
    Reddy, Srinivasa T.
    Charles-Schoeman, Christina
    RHEUMATOLOGY, 2022, 61 (06) : 2512 - 2523
  • [28] Naphthoquinones, benzoquinones, and anthraquinones: Molecular docking, ADME and inhibition studies on human serum paraoxonase-1 associated with cardiovascular diseases
    Demir, Yeliz
    DRUG DEVELOPMENT RESEARCH, 2020, 81 (05) : 628 - 636
  • [29] Correlation between lipoprotein(a) and lipid peroxidation in psoriasis: role of the enzyme paraoxonase-1
    Ferretti, G.
    Bacchetti, T.
    Campanati, A.
    Simonetti, O.
    Liberati, G.
    Offidani, A.
    BRITISH JOURNAL OF DERMATOLOGY, 2012, 166 (01) : 204 - 207
  • [30] Hepatic dysmetabolism in polycystic ovarian syndrome: impact of paraoxonase-1 modulation by butyrate
    Areloegbe S.E.
    Oyekanmi O.A.
    Ajadi I.O.
    Ajadi M.B.
    Atuma C.L.
    Aturamu A.
    Olaniyi K.S.
    Comparative Clinical Pathology, 2024, 33 (4) : 623 - 632
12345